Stock Information
Entrada Therapeutics Inc (TRDA)
Ticker Symbol: TRDA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $502.58 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.4708
Revenue (TTM): $0.61 M
Dividend Yield: N/A%
ROE: -39.83%
Latest News
-
Oppenheimer Maintains Outperform on Entrada Therapeutics, Raises Price Target to $23
Mon, Apr 6, 2026 9:20 AM
Key Financials
Financial data not available